|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 |
| (11) | Number of the document | 2117517 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08727550.9 |
| Date of filing the European patent application | 2008-01-10 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-06-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/050796 |
| Date | 2008-01-10 |
| (87) | Number | WO 2008/086492 |
| Date | 2008-07-17 |
| (30) | Number | Date | Country code |
| 884598 P | 2007-01-11 | US |
| (72) |
KIDNEY, David, J., US
CUNDY, Kenneth, C., US
SASTRY, Srikonda, US
LEUNG, Manshiu, US
|
| (73) |
XenoPort, Inc.,
3410 Central Expressway, Santa Clara, CA 95051,
US
|
| (54) | SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT |
| SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT |